Aclaris Therapeutics, Inc. (ACRS) Gross margin 2017–2018
Aclaris Therapeutics, Inc. (ACRS) gross margin by fiscal year — reported gross profit divided by reported revenue.
52.7%FY2018 · since FY2017: 28.3% → 52.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2018 | 52.7% | +24.4 pp |
| FY2017 | 28.3% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice